BlackRock, Inc. 13D and 13G filings for Aldeyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
3,430,774 5.800% |
2,455,827 (+251.89%) |
Filing |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
974,947 1.700% |
-2,253,864 (-69.80%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
3,228,811 5.600% |
2,745,238 (+567.70%) |
Filing |
| 2020-07-10 10:39 am Sale |
2020-06-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
483,573 1.600% |
-1,101,052 (-69.48%) |
Filing |